We are live on ! Find out more
CG

Carmignac Gestion Portfolio holdings

AUM $6.51B
1-Year Est. Return 19.13%
This Fund
S&P 500
This Quarter Est. Return
+13.27%
1 Year Est. Return
+19.13%
3 Year Est. Return
+94.32%
5 Year Est. Return
+115.43%
10 Year Est. Return
+608.92%
AUM
$5.54B
AUM Growth
+$883M
Cap. Flow
+$368M
Cap. Flow %
6.64%
Top 10 Hldgs %
44.52%
Holding
154
New
27
Increased
59
Reduced
33
Closed
19

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$243M
2
SYK icon
Stryker
SYK
+$161M
3
AMD icon
Advanced Micro Devices
AMD
+$138M
4
BEKE icon
KE Holdings
BEKE
+$117M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$81.5M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$231M
2
SLB icon
SLB Ltd
SLB
+$158M
3
CTLT
CATALENT, INC.
CTLT
+$128M
4
CRM icon
Salesforce
CRM
+$71M
5
COST icon
Costco
COST
+$65.3M

Sector Composition

Rank Sector Weight
1 Healthcare 22.83%
2 Technology 20.78%
3 Consumer Discretionary 16.78%
4 Financials 10.4%
5 Materials 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WDAY icon
76
Workday
WDAY
$35.8B
$3.86M 0.07%
23,091
-40,869
-64% -$6.37M
ZH
77
Zhihu
ZH
$273M
$3.85M 0.07%
+493,635
New +$3.46M
PFE icon
78
Pfizer
PFE
$143B
$3.61M 0.07%
70,456
+37,312
+113% +$1.79M
BIDU icon
79
Baidu
BIDU
$36.5B
$3.59M 0.06%
31,365
-22,771
-42% -$2.32M
CPRT icon
80
Copart
CPRT
$25.6B
$3.31M 0.06%
108,618
+11,922
+12% +$357K
ISRG icon
81
Intuitive Surgical
ISRG
$122B
$3.14M 0.06%
11,796
+1,741
+17% +$425K
VEEV icon
82
Veeva Systems
VEEV
$31.7B
$2.96M 0.05%
18,312
+2,503
+16% +$428K
CTAS icon
83
Cintas
CTAS
$81.8B
$2.72M 0.05%
24,052
– –
CLSD
84
DELISTED
Clearside Biomedical
CLSD
$2.69M 0.05%
160,023
– –
HXL icon
85
Hexcel
HXL
$7.83B
$2.55M 0.05%
43,305
-13,693
-24% -$784K
PAYX icon
86
Paychex
PAYX
$40.7B
$2.53M 0.05%
21,892
– –
LRCX icon
87
Lam Research
LRCX
$392B
$2.52M 0.05%
+60,000
New +$2.51M
PINS icon
88
Pinterest
PINS
$13B
$2.52M 0.05%
+103,806
New +$2.48M
MAR icon
89
Marriott International
MAR
$96.6B
$2.45M 0.04%
16,464
– –
CRM icon
90
Salesforce
CRM
$140B
$2.34M 0.04%
17,648
-486,835
-97% -$71M
JPM icon
91
JPMorgan Chase
JPM
$907B
$2.01M 0.04%
15,000
+5,000
+50% +$634K
TRU icon
92
TransUnion
TRU
$15.4B
$1.87M 0.03%
32,826
+8,407
+34% +$493K
TSLA icon
93
Tesla
TSLA
$1.43T
$1.85M 0.03%
15,000
-68,292
-82% -$12.9M
TDCX
94
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
$1.71M 0.03%
137,624
+31,155
+29% +$372K
SEDG icon
95
SolarEdge
SEDG
$3.25B
$1.69M 0.03%
5,975
– –
BRO icon
96
Brown & Brown
BRO
$23.5B
$1.68M 0.03%
29,474
+1,638
+6% +$95.8K
ALGN icon
97
Align Technology
ALGN
$12.7B
$1.68M 0.03%
7,935
+2,072
+35% +$415K
DAR icon
98
Darling Ingredients
DAR
$10B
$1.65M 0.03%
26,419
+12,330
+88% +$870K
GRMN
99
Garmin
GRMN
$48.1B
$1.64M 0.03%
17,800
– –
SXT icon
100
Sensient Technologies
SXT
$4.64B
$1.6M 0.03%
22,000
+16,000
+267% +$1.15M
2 3
4
5 6

Similar funds

TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $6.53B AUM 20.48% 1-Year Est. Return
RCWMU
Rothschild & Co Wealth Management (UK) London, United Kingdom $6.53B AUM 0.87% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
BF
BOK Financial Tulsa, Oklahoma $6.54B AUM 25.41% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $6.46B AUM 18.45% 1-Year Est. Return
LAM
Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

Carmignac Gestion's Q4 2022 Portfolio in Review

As of Q4 2022, Carmignac Gestion held 154 positions worth $5.54B, up 19% from $4.65B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Carmignac Gestion deployed $368M of net new capital in Q4 2022, opening 27 new positions and adding to 59 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 868,612 shares worth $89.9M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Amazon, an estimated $231M trimmed.

  • Carmignac Gestion's largest Q4 2022 buy was BioMarin Pharmaceuticals: 868,612 shares worth $89.9M.
  • Carmignac Gestion added most to Alibaba in Q4 2022, an estimated $243M increase.
  • Carmignac Gestion's biggest Q4 2022 reduction was Amazon, cutting an estimated $231M.
  • Carmignac Gestion fully exited CATALENT, INC. in Q4 2022, selling an estimated $128M.
  • Carmignac Gestion's ten largest holdings make up 45% of its $5.54B portfolio in Q4 2022.
  • Carmignac Gestion opened 27 new positions and closed 19 in Q4 2022.
  • Carmignac Gestion's portfolio value rose 19% quarter-over-quarter to $5.54B.

Based on Carmignac Gestion's 13F filing for Q4 2022, filed 13 Feb 2023.